REGENERON PHARMACEUTICALS INC COM STK USD0.001 earnings per share and revenue

0R2M earnings per share for the last quarter are 12.07 USD whereas the estimation was 11.28 USD which accounts for 6.98% surprise. Company revenue for the same period amounts to 3.79 B USD despite the estimated figure of 3.74 B USD. Estimated earnings per share for the next quarter are 9.55 USD, and revenue is expected to reach 3.43 B USD. Also watch annual changes over time to get a bigger picture of 0R2M earnings per share and revenue dynamics.